Related Experiment Video

Updated: Aug 7, 2026

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
09:39

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications

Published on: January 27, 2014

Agonist-induced functional desensitization of recombinant human 5-HT2 receptors expressed in CHO-K1 cells

R H Porter1, C S Malcolm, N H Allen

  • 1Vernalis Research Ltd, Oakdene Court, 613 Reading Road, Winnersh, Wokingham, RG41 5UA, United Kingdom. richard.porter@roche.com

Biochemical Pharmacology
|July 13, 2001
PubMed

Insights

Recombinant serotonin 5-HT(2) receptors show varied desensitization. RNA editing influences 5-HT(2C) receptor desensitization, with the INI isoform desensitizing more than the VSV isoform.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • Serotonin 5-HT(2) receptors are crucial in the central nervous system.
  • RNA editing significantly impacts 5-HT(2C) receptor function.
  • Understanding receptor desensitization is key to developing targeted therapeutics.

Purpose of the Study:

  • To investigate and compare the desensitization characteristics of human 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptors (VSV and INI isoforms).
  • To evaluate the desensitization effects of different agonists: serotonin (5-HT), m-chlorophenylpiperazine (mCPP), and 2,5-dimethoxy-4-iodoamphetamine hydrobromide (DOI).
  • To examine heterologous desensitization of G(q/11)-coupled purinergic receptors.

Main Methods:

  • Stable expression of recombinant human 5-HT receptor isoforms in CHO-K1 cells.
  • Calcium fluorimetry to measure receptor desensitization.
  • Application of various agonists (5-HT, mCPP, DOI) to assess homologous and heterologous desensitization.

Main Results:

  • Human 5-HT(2C (INI)) receptors desensitized more than 5-HT(2C (VSV)) receptors to all tested agonists.
  • 5-HT(2B) receptors showed the most significant desensitization (80% reduction) with rapid kinetics.
  • 5-HT(2A) receptor response reduced by 54%; partial agonists showed rapid desensitization.
  • Only 5-HT(2C (VSV)) receptor stimulation led to profound heterologous desensitization of purinergic receptors.

Conclusions:

  • Significant differences exist in homologous and heterologous desensitization among 5-HT(2) receptor subtypes.
  • RNA editing-induced signal transduction differences likely explain the distinct desensitization profiles of 5-HT(2C (INI)) and 5-HT(2C (VSV)) receptors.
  • These findings provide insights into the complex regulation of serotonin receptor signaling.

More Related Videos

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice07:30

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice

Published on: July 9, 2016

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Spare Receptors01:30

Spare Receptors

Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...